Revenue for Edwards Lifesciences (EW)
According to Edwards Lifesciences's latest reported financial statements, the company's current revenue (TTM) is $6.30B USD. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings (not a live revenue-per-second estimate).
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingRevenueSwitch metric
TTM (last 4 quarters)
$6.30B
YoY change
+11.5%
5Y CAGR
+6.7%
Peak year (2025)
$6.07B
Cumulative revenue
$68.46B
Revenue history chart for Edwards Lifesciences (EW) from 1999 to 2025
Revenue history table for Edwards Lifesciences (EW) from 1999 to 2025
| Fiscal year | Period ended | Reported | Revenue | YoY |
|---|---|---|---|---|
| 2025 | $6.07B | +11.5% | ||
| 2024 | $5.44B | +8.6% | ||
| 2023 | $5.01B | -6.9% | ||
| 2022 | $5.38B | +2.9% | ||
| 2021 | $5.23B | +19.3% | ||
| 2020 | $4.39B | +0.9% | ||
| 2019 | $4.35B | +16.8% | ||
| 2018 | $3.72B | +8.4% | ||
| 2017 | $3.44B | +15.9% | ||
| 2016 | $2.96B | +18.8% | ||
| 2015 | $2.49B | +7.4% | ||
| 2014 | $2.32B | +13.6% | ||
| 2013 | $2.05B | +7.7% | ||
| 2012 | $1.90B | +13.2% | ||
| 2011 | $1.68B | +16.0% | ||
| 2010 | $1.45B | +9.5% | ||
| 2009 | $1.32B | +6.8% | ||
| 2008 | $1.24B | +13.4% | ||
| 2007 | $1.09B | +5.2% | ||
| 2006 | $1.04B | +3.9% | ||
| 2005 | $997.90M | +7.1% | ||
| 2004 | $931.50M | +8.3% | ||
| 2003 | $860.50M | +22.2% | ||
| 2002 | $704.00M | +1.7% | ||
| 2001 | $692.00M | -13.9% | ||
| 2000 | $804.00M | -11.2% | ||
| 1999 | $905.00M | — |
Revenue values are taken from Edwards Lifesciences's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Edwards Lifesciences (EW) most recent annual revenue stands at $6.07B (2025) – grew 11.5% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Edwards Lifesciences revenue compounded at +6.7% per year, sustaining 2 straight years of year-over-year growth.
The highest annual revenue of $6.07B was reported in 2025. The lowest in the available history was $692.00M in 2001.
Within Healthcare, Edwards Lifesciences (EW) ranks 9th among 8 peers we track. The peer median for revenue is $65.09B.
Edwards Lifesciences Revenue by Year
Edwards Lifesciences Revenue 2025: $6.07B
Edwards Lifesciences revenue in 2025 was $6.07B, grew 11.5% from 2024. This figure represents the highest annual value in the available history.
Edwards Lifesciences Revenue 2024: $5.44B
Edwards Lifesciences revenue in 2024 was $5.44B, grew 8.6% from 2023.
Edwards Lifesciences Revenue 2023: $5.01B
Edwards Lifesciences revenue in 2023 was $5.01B, declined 6.9% below 2022.
Edwards Lifesciences Revenue 2022: $5.38B
Edwards Lifesciences revenue in 2022 was $5.38B, edged up 2.9% from 2021.
Edwards Lifesciences Revenue 2021: $5.23B
Edwards Lifesciences revenue in 2021 was $5.23B.
See more financial history for Edwards Lifesciences (EW).
Sector peers — Revenue
Companies in the same sector as Edwards Lifesciences, ranked by their latest revenue.
| Company | Revenue | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $447.57B | Healthcare |
| Novo Nordisk A/S (NVO) | $309.06B | Healthcare |
| Johnson & Johnson (JNJ) | $94.19B | Healthcare |
| Eli Lilly and Company (LLY) | $65.18B | Healthcare |
| Merck & Co., Inc. (MRK) | $65.01B | Healthcare |
| AbbVie Inc. (ABBV) | $61.16B | Healthcare |
| AstraZeneca PLC (AZN) | $58.74B | Healthcare |
| Amgen Inc. (AMGN) | $36.74B | Healthcare |
Frequently asked questions
What is Edwards Lifesciences's revenue?
- Latest reported revenue for Edwards Lifesciences (EW) is $6.30B (period ending March 31, 2026).
How has Edwards Lifesciences revenue changed year-over-year?
- Edwards Lifesciences (EW) revenue changed +11.5% year-over-year on the latest annual filing.
What is the long-term growth rate of Edwards Lifesciences revenue?
- Edwards Lifesciences (EW) revenue compound annual growth rate is +6.7% over the most recent 5 years available.
When did Edwards Lifesciences revenue hit its highest annual value?
- Edwards Lifesciences revenue reached its highest annual value of $6.07B in 2025.
What was Edwards Lifesciences revenue in 2024?
- Edwards Lifesciences (EW) revenue in 2024 was $5.44B.
What was Edwards Lifesciences revenue in 2025?
- Edwards Lifesciences (EW) revenue in 2025 was $6.07B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
EW Overview
Company profile, financial tools, and key metrics
EW Revenue Counter
Earns $199.88 every second. See per minute, hour, and day.
EW Earnings Counter
Earns $34.65 per second net profit. See per minute, hour, and day.
EW Economic Scale
Exceeds Fiji's GDP. Compare with world economies.
EW What If Invested
What if you had invested $1,000? See historical returns from any date.
EW How It Makes Money
Discover visual breakdown of $6.30B in revenue — where it comes from and where it goes.
EW Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
EW Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
EW Daily Price Character
Balanced · 50.0% historical win rate (green days). Streaks & record days.
EW Buybacks
0.93% TTM buyback yield. Shareholder yield & SBC comparison.
EW Stock Split History
3 splits on record. Dates, ratios, and cumulative multiple.